Highlights: Zenocutuzumab blocks HER2/3 proteins to treat NRG1 fusion cancers FDA's approval is based on promisi

On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic...

On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for...

The FDA issues a complete response letter to JNJ's BLA seeking approval for the subcutaneous formulation of Rybrevant in EGFR-mutated non-small cell...

9 December 2024 -- Datopotamab deruxtecan (Dato-DXd) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of adult...

TUESDAY, Dec. 10, 2024 -- In non-small cell lung cancer (NSCLC) patients with overweight or obesity, metformin may improve lung cancer-specific...

Non-communicable diseases, including cancers such as lung, liver, and breast cancer, account for 77 per cent of total deaths in Việt Nam. This...

Non-communicable diseases, including cancers such as lung, liver, and breast cancer, account for 77 per cent of total deaths in Việt Nam. This...

NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...